CLL: Mayo Clinic's approach to diagnosis
Approximately 20,000 patients will be diagnosed with chronic lymphocytic leukemia (CLL) in the United States alone in 2019. Many of these patients will be in the early-stage of their disease at the time of their diagnosis and will not meet indications for therapy (learn more about this period known as watch & wait).
It is now possible for Mayo Clinic hematologists to identify several prognostic markers to individually predict which patients are at a higher risk of progression. Learn more about the five variables providers use to determine who is at a higher risk in Dr. Parikh's video below: